Cargando…

A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency

BACKGROUND: Premature ovarian insufficiency (POI) is a clinical syndrome occurring in women before 40 with decreased ovarian function. Up to 25% of POI cases result from genetic factors that remain largely unknown. The Excision repair cross‐complementing, group 6 (ERCC6) variant has been found to ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Lele, Liu, Bin, Xi, Di, Gao, Yuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544206/
https://www.ncbi.nlm.nih.gov/pubmed/35975393
http://dx.doi.org/10.1002/mgg3.2040
_version_ 1784804547208675328
author Kuang, Lele
Liu, Bin
Xi, Di
Gao, Yuping
author_facet Kuang, Lele
Liu, Bin
Xi, Di
Gao, Yuping
author_sort Kuang, Lele
collection PubMed
description BACKGROUND: Premature ovarian insufficiency (POI) is a clinical syndrome occurring in women before 40 with decreased ovarian function. Up to 25% of POI cases result from genetic factors that remain largely unknown. The Excision repair cross‐complementing, group 6 (ERCC6) variant has been found to cause POI, which is hardly ever diagnosed in adolescents. METHODS: Whole‐exome sequencing was performed on a 19‐year‐old proband with non‐syndromic POI and her parents. Sanger sequencing was used to confirm the identified variant. The effect of the variant on the protein was analyzed in silico and Swiss‐MODEL. RESULTS: A novel heterozygous missense variant, c.2444G > A (p. GLy815Asp) of ERCC6 was identified in the proband who inherited the variant from her father. The variant was confirmed in another POI patient from the pedigree and was absent in the proband's mother and sister who presented normally. In silico analysis predicted this variant was deleterious. Swiss‐Model revealed that the mutant amino acid formed multiple H‐bonds with adjacent residues, which may lead to a dysfunction of ERCC6 protein. CONCLUSION: We firstly diagnosed an adolescent POI case associated with a novel heterozygous ERCC6 variant. The results expanded the variants spectrum of ERCC6 and provided guidance for POI diagnosis and genetic counselling.
format Online
Article
Text
id pubmed-9544206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95442062022-10-14 A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency Kuang, Lele Liu, Bin Xi, Di Gao, Yuping Mol Genet Genomic Med Original Articles BACKGROUND: Premature ovarian insufficiency (POI) is a clinical syndrome occurring in women before 40 with decreased ovarian function. Up to 25% of POI cases result from genetic factors that remain largely unknown. The Excision repair cross‐complementing, group 6 (ERCC6) variant has been found to cause POI, which is hardly ever diagnosed in adolescents. METHODS: Whole‐exome sequencing was performed on a 19‐year‐old proband with non‐syndromic POI and her parents. Sanger sequencing was used to confirm the identified variant. The effect of the variant on the protein was analyzed in silico and Swiss‐MODEL. RESULTS: A novel heterozygous missense variant, c.2444G > A (p. GLy815Asp) of ERCC6 was identified in the proband who inherited the variant from her father. The variant was confirmed in another POI patient from the pedigree and was absent in the proband's mother and sister who presented normally. In silico analysis predicted this variant was deleterious. Swiss‐Model revealed that the mutant amino acid formed multiple H‐bonds with adjacent residues, which may lead to a dysfunction of ERCC6 protein. CONCLUSION: We firstly diagnosed an adolescent POI case associated with a novel heterozygous ERCC6 variant. The results expanded the variants spectrum of ERCC6 and provided guidance for POI diagnosis and genetic counselling. John Wiley and Sons Inc. 2022-08-16 /pmc/articles/PMC9544206/ /pubmed/35975393 http://dx.doi.org/10.1002/mgg3.2040 Text en © 2022 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Kuang, Lele
Liu, Bin
Xi, Di
Gao, Yuping
A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title_full A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title_fullStr A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title_full_unstemmed A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title_short A novel heterozygous ERCC6 variant identified in a Chinese family with non‐syndromic primary ovarian insufficiency
title_sort novel heterozygous ercc6 variant identified in a chinese family with non‐syndromic primary ovarian insufficiency
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544206/
https://www.ncbi.nlm.nih.gov/pubmed/35975393
http://dx.doi.org/10.1002/mgg3.2040
work_keys_str_mv AT kuanglele anovelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT liubin anovelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT xidi anovelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT gaoyuping anovelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT kuanglele novelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT liubin novelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT xidi novelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency
AT gaoyuping novelheterozygousercc6variantidentifiedinachinesefamilywithnonsyndromicprimaryovarianinsufficiency